Table 1. Clinical features of sustained and non-sustained virological response patients with chronic hepatitis C.
| Characteristic | All | SVR | Non-SVR | P |
|---|---|---|---|---|
| (n = 115) | (n = 56) | (n = 59) | ||
| Age (yr) | 60 (24 - 80) | 59 (25 - 80) | 60 (24 - 75) | 0.43 |
| Male | 66 (57) | 34 (61) | 32 (54) | 0.48 |
| Alanine aminotransferase (IU/L) | 46 (17 - 389) | 48 (17 - 389) | 45 (17 - 309) | 0.81 |
| Aspartate aminotransferase (IU/L) | 43 (17 - 246) | 42 (17 - 231) | 43 (17 - 246) | 0.49 |
| White blood cells (/μL) | 4410 (2280 - 8240) | 4740 (2700 - 8170) | 4070 (2280 - 8240) | 0.011 |
| Hemoglobin (g/dL) | 14.4 (9.2 - 18.2) | 15.1 (11.0 - 18.2) | 13.9 (9.2 - 17.4) | 0.002 |
| Platelet count (104/μL) | 15.9 (6.7 - 33.6) | 16.6 (8.3 - 26.2) | 15.6 (6.7 - 33.6) | 0.30 |
| APRI | 0.89 (0.21 - 5.40) | 0.59 (0.22 - 5.40) | 0.66 (0.21 - 5.06) | 0.41 |
| HCV RNA (log10 IU/mL) | 6.4 (5.0 - 7.3) | 6.1 (5.0 - 6.8) | 6.5 (5.0 - 7.3) | < 0.001 |
Data are expressed as median (range) or n (%) as appropriate. SVR, sustained virological response; HCV, hepatitis C virus